GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 65 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | – | 7,037 | +1210.4% | 0.00% | – |
| Q4 2018 | $0 | – | 537 | -0.4% | 0.00% | – |
| Q3 2018 | $0 | – | 539 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 539 | -0.2% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 540 | -10.9% | 0.00% | – |
| Q4 2017 | $1,000 | -80.0% | 606 | -80.2% | 0.00% | – |
| Q3 2017 | $5,000 | +66.7% | 3,059 | +480.5% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 527 | +3.5% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 509 | +1.4% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 502 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -62.5% | 502 | -73.6% | 0.00% | – |
| Q2 2016 | $8,000 | +14.3% | 1,900 | +111.1% | 0.00% | – |
| Q1 2016 | $7,000 | +40.0% | 900 | -8.3% | 0.00% | – |
| Q4 2015 | $5,000 | -54.5% | 981 | -34.4% | 0.00% | – |
| Q3 2015 | $11,000 | -56.0% | 1,495 | -17.9% | 0.00% | – |
| Q2 2015 | $25,000 | – | 1,822 | +8181.8% | 0.00% | – |
| Q4 2014 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $8,071,000 | 8.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 709,271 | $2,908,000 | 0.76% |
| AWM Investment Company, Inc. | 778,849 | $3,193,000 | 0.68% |
| AlphaMark Advisors, LLC | 226,740 | $930,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 756,017 | $3,100,000 | 0.37% |
| Rock Springs Capital Management LP | 480,000 | $1,968,000 | 0.15% |
| Birchview Capital, LP | 39,000 | $160,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 687,257 | $2,818,000 | 0.11% |
| Alpine Global Management, LLC | 29,169 | $120,000 | 0.06% |
| TFS CAPITAL LLC | 32,554 | $133,000 | 0.02% |